新发间变性脑膜瘤中切除程度与辅助放疗的预后作用
这项回顾性多中心研究纳入1999至2021年间手术的新发间变性脑膜瘤患者65例,经2016年WHO标准集中病理复核。中位无进展生存期23个月,中位总生存期2年;辛普森分级对总生存无影响,全切除联合辅助放疗与无进展生存期改善相关。
要点
- 新发间变性脑膜瘤患者65例,中位无进展生存期23个月,中位总生存期2年。
- 辛普森分级对总生存无影响,单独切除质量或单独辅助放疗均不能预测总生存改善。
- 全切除联合辅助放疗与无进展生存期改善相关(HR=0.47,95%CI 0.24-0.92,P=0.027)。
核心结论
- 辛普森分级对总生存无影响;在本新发间变性脑膜瘤队列中,全切除联合辅助放疗对无进展生存期有有利影响。
研究设计与样本
- 回顾性多中心研究,纳入1999至2021年间手术的新发间变性脑膜瘤患者,所有病例采用2016年WHO标准进行集中病理复核,排除有放疗史或NF2相关神经鞘瘤病患者,共65例。
主要发现
- 中位无进展生存期为23个月,中位总生存期为2年。
- 单因素分析中,无进展生存期受全切除联合辅助放疗(HR=0.47,95%CI 0.24-0.92,P=0.027)和诊断时年龄(HR=2.92,95%CI 1.38-6.21,P=0.005)影响。
- 间变性肿瘤中,按核分裂数分级者预后差于按明显间变分级者。
- 在高核分裂评分(>20/10HPF)的间变性肿瘤中,单因素分析显示无进展生存期受术后放疗(HR=0.44,95%CI 0.22-0.88,P=0.020)及全切除联合辅助放疗(HR=0.44,95%CI 0.21-0.90,P=0.024)影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Grade 3 meningiomas, although rare, are associated with high morbidity and mortality. The respective impacts of extent of surgical resection and adjuvant radiotherapy are still debated. Moreover, anaplastic meningiomas are studied in heterogenous cohort of de novo and progressive anaplastic tumors. METHODS: We conducted a retrospective multicentric study on patients operated from a de novo anaplastic meningioma between 1999 and 2021. A centralized pathological review using 2016 WHO criteria was performed for all cases. Patients with history of radiotherapy or NF2-related Schwannomatosis were excluded. RESULTS: Sixty-five patients were included in the study. Median progression free survival was 23 months and median overall survival was 2 years. Neither quality of resection nor adjuvant radiotherapy alone were predictive of better overall survival. Progression free survival were impacted by combination of gross-total resection and adjuvant radiotherapy (HR = 0.47 CI95% = [0.24-0.92], p = 0.027) and age at diagnosis (HR = 2.92 CI95% = [1.38-6.21], p = 0.005) in univariate analyses. Within anaplastic tumors, those graded on mitosis number had a poorer prognosis than those graded on overt anaplasia. Among anaplastic tumors with high mitotic score (> 20/10HPF), progression free survival were impacted by postoperative radiotherapy (HR = 0.44 CI95% = [0.22-0.88], p = 0.020) and gross total resection and adjuvant radiotherapy association (HR = 0.44 CI95% = [0.21-0.90], p = 0.024) in univariate analyses. CONCLUSION: Simpson grade didn't show any impact on overall survival. Gross total resection + adjuvant radiotherapy favorably impacted progression free survival in our cohort of de novo anaplastic meningiomas.
引用
- Marijon P, Planet M, Tran S, et al. Prognostic role of extent of resection and adjuvant radiotherapy in de novo anaplastic meningiomas. Acta Neurochir (Wien). 2024. PMID: 39607523. doi:10.1007/s00701-024-06336-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。